In June 2022, the Paul-Ehrlich-Institut organised a two-day virtual expert workshop on behalf of the COMBINE project. The workshop aimed to address the challenges in developing monoclonal antibodies (mAbs) against antimicrobial resistance (AMR) pathogens, with a specific focus on ESCAPE pathogens (E. faecium, S. aureus, C. difficile, A. baumannii, P. aeruginosa, and Enterobacteriaceae). The workshop […]
Recap of the third UNITE4TB webinar: Progress made to date in shortening TB treatment UNITE4TB held its third public webinar on Thursday 7 July, with a focus on the recent changes in the World Health Organization (WHO) guidelines for the treatment of Tuberculosis (TB) and an evaluation of the evidence underpinning the shortening of TB […]
About twenty people attended this webinar which focused on some highlights and challenges from three TB focused projects, namely UNITE4TB, ERA4TB, and TRIC-TB. The selected speakers, Modesto Remuinan-Blanco (TRIC-TB and GSK), Martin Boeree (UNITE4TB and Radboud UMC), Alfonso Mendoza-Losana (ERA4TB and Universidad Carlos III Madrid) and Oscar della Pasqua (ERA4TB and Consiglia Nazionale delle Ricerche) […]
ERA4TB launched a series of webinars aimed at exploring key topics in relation to tuberculosis and antimicrobial research and development from clinical, regulatory and HTA perspectives. With the title “Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives”, the first webinar was held on 24th November 2022, 11.00-12.15 GMT coinciding with World Antimicrobial Awareness […]
About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on machine learning (ML). First, all attendees introduced themselves and outlined their interest in ML. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions) and Philip Gribbon, SIG Leader, Fraunhofer ITMP introduced the ML Scientific Interest Group (SIG) and its charter. Daniel […]
About fifteen people attended the kick-off meeting of the Scientific Interest Group (SIG) on animal models. First, all attendees introduced themselves and outlined which models they currently use in their project. Frederik Deroose, SIG Chairman, Connecting Pharma (ex-Asclepia Outsourcing Solutions), SIG Chairman and Carina Vingsbo Lundberg, SIG Leader, Statens Serum Institut introduced the Animal Models […]
Fourteen partners attended this second meeting of the Machine Learning (ML) Scientific Interest Group (SIG), which focused on the practical application of Artificial Intelligence (AI) and Machine Learning methods in antimicrobial drug discovery (ADD). Artificial intelligence concerns the study and development of machines that are capable of learning and problem-solving, thus natural intelligence. A "worked […]
About ten people attended this second meeting with the Scientific Interest Group (SIG) on animal models. As a follow up from the previous SIG meeting, this event focused on “Data Cataloging of animal infection models.”. The attendees contributed to this first version of the in vivo catalog with information about their resources and infection models […]